ICAM1 and cancer: Human and mouse cancer patients had CTC–neutrophil microaggregates in circulation; the CTCs included in the clusters were highly metastatic and proliferative, which is consistent with ICAM-1+ CTCs having higher levels of tumor stemness [405].